170921-48-9

Basic information

• Product Name: 8-Benzyl-1,3,8-triaza-spiro[4.5]decan-4-one
• Synonyms: 8-Benzyl-1,3,8-triaza-spiro[4.5]decan-4-one;1,3,8-Triazaspiro[4.5]decan-4-one, 8-(phenylmethyl)-
• CAS NO: 170921-48-9
• Molecular Formula: C₁₄H₁₉N₃O
• Molecular Weight: 245.32016
• Mol File: 170921-48-9.mol
• Article Data: 2

Chemical Properties

• Melting Point: 70-72 °C
• Boiling Point: 451.4±45.0 °C(Predicted)
• Appearance: /
• Density: 1.20±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C(protect from light)
• PKA: 15.17±0.20(Predicted)
• CAS DataBase Reference: 8-Benzyl-1,3,8-triaza-spiro[4.5]decan-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: 8-Benzyl-1,3,8-triaza-spiro[4.5]decan-4-one(170921-48-9)
• EPA Substance Registry System: 8-Benzyl-1,3,8-triaza-spiro[4.5]decan-4-one(170921-48-9)

Safety Data

• Hazardous Substances Data: 170921-48-9(Hazardous Substances Data)

Usage

General Description

8-Benzyl-1,3,8-triaza-spiro[4.5]decan-4-one is a chemical compound with the molecular formula C16H21N3O. It is a spirocyclic compound, meaning it contains a ring structure in which two atoms are connected to the same atom but not to each other. 8-Benzyl-1,3,8-triaza-spiro[4.5]decan-4-one is used in the field of medicinal chemistry and drug discovery, where it may have potential applications as a pharmaceutical agent. The benzyl group attached to the nitrogen atom suggests that this compound may have biological activity and could be a potential lead compound for drug development. Further research and testing are needed to fully understand the properties and potential uses of 8-Benzyl-1,3,8-triaza-spiro[4.5]decan-4-one.

Upstream product

• 170921-49-0 N-benzyl-4-amino-piperidine-4-carboxamide 
• 136624-42-5 4-amino-1-benzylpiperidine-4-carbonitrile 
• 3612-20-2 1-phenylmethyl-4-piperidone 

Downstream Products

• 851338-35-7 8-benzyl-1-(3-methyl-butyl)-1,3,8-triaza-spiro[4.5]decan-4-one 
• 170921-52-5 8-[4-(4-fluoro-phenyl)-4-oxo-butyl]-1,3,8-triaza-spiro[4.5]decan-4-one 

Relevant articles and documents

Discovery of a highly selective PLD2 inhibitor (ML395): A new probe with improved physiochemical properties and broad-spectrum antiviral activity against influenza strains

Further chemical optimization of the halopemide-derived family of dual phospholipase D1/2 (PLD1/2) inhibitors afforded ML395 (VU0468809), a potent, >80-fold PLD2 selective allosteric inhibitor (cellular PLD1, IC50>30 000 nm; cellular PLD2, IC50=360 nm). Moreover, ML395 possesses an attractive in vitro DMPK profile, improved physiochemical properties, ancillary pharmacology (Eurofins Panel) cleaner than any other reported PLD inhibitor, and has been found to possess interesting activity as an antiviral agent in cellular assays against a range of influenza strains (H1, H3, H5 and H7).